Praxis Precision Medicines, Inc. (PRAX)

Healthcare · Biotechnology · NASDAQ

Praxis Precision Medicines, Inc. (PRAX) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $8.39B and a free-cash-flow yield of -3.7%. Over the most recent reported fiscal year, revenue declined 100.0%.

Market cap	$8.39B
Trailing P/E	—
FCF yield	-3.7%
Revenue growth (YoY)	-100.0%
EPS growth (YoY)	—
FCF/share growth (YoY)	—
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology

Explore live PRAX data on Nama Insights →

Recent Congressional trades

Praxis Precision Medicines, Inc. trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member	Chamber	Trade	Amount	Disclosed
Gilbert Cisneros	House	Buy	$1,001 - $15,000	Sep 4, 2026